Mind Medicine (MindMed) Inc reports results for the quarter ended June 30 - Earnings Summary
31/07/2025 22:00
Mind Medicine (MindMed) Inc MNMD.OQ reported a quarterly adjusted loss of 50 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -26 cents. The mean expectation of nine analysts for the quarter was for a loss of 36 cents per share. Wall Street expected results to range from -40 cents to -29 cents per share. Reported revenue was zero; analysts expected zero. Mind Medicine (MindMed) Inc's reported EPS for the quarter was a loss of 50 cents. The company reported a quarterly loss of $42.74 million. Mind Medicine (MindMed) Inc shares had risen by 39.1% this quarter and gained 29.7% so far this year. FORECAST CHANGES The mean earnings estimate of analysts had risen by about 4.8% in the last three months. In the last 30 days, one analyst negatively revised an earnings estimate RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." Wall Street's median 12-month price target for Mind Medicine (MindMed) Inc is $20.00, about 54.9% above its last closing price of $9.03 This summary was machine generated from LSEG data July 31 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Jun. 30 2025 | -0.36 | -0.50 | Missed |
| Mar. 31 2025 | -0.37 | -0.27 | Beat |
| Dec. 31 2024 | -0.30 | -0.41 | Missed |
| Sep. 30 2024 | -0.28 | -0.27 | Beat |